Recap: Seres Therapeutics Q1 Earnings

 

Seres Therapeutics MCRB reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Earnings

Seres Therapeutics missed estimated earnings by 17.31%, reporting an EPS of $-0.61 versus an estimate of $-0.52.

Revenue was down $4.22 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.11 which was followed by a 0.34% increase in the share price the next day.

Here's a look at Seres Therapeutics's past performance:

 

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.44 -0.46 -0.37 -0.31
EPS Actual -0.55 0.72 -0.53 -0.39
Revenue Estimate 12.25M 7.32M 5.34M 6.45M
Revenue Actual 7.22M 126.72M 5.26M 5.72M

To track all earnings releases for Seres Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!